Novo nordisk enters into exclusive negotiations to acquire a controlling stake in bicorp, to be followed by a tender offer on all remaining shares.

BagsvÆrd, denmark & issoire, france--(business wire)-- #digitalhealth--regulatory news: novo nordisk a/s and biocorp production sa (paris:alcor) announced today that novo nordisk has entered into exclusive negotiations for a controlling stake in biocorp, which would be followed by a mandatory simplified tender offer on all remaining outstanding shares in biocorp1 at a price of 35.00 euros per share in cash, representing a total equity value of approximately 154 million euros. biocorp is a french company special.
NVO Ratings Summary
NVO Quant Ranking